Setmelanotide
Open-Label Extension Study of Setmelanotide
Rhythm · Phase 3 · Completed · Enrollment 28
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Setelanotide (Open-label) | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Setmelanotide
Rhythm · Phase 3 · Completed · Enrollment 28
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Setelanotide (Open-label) | Obesity or overweight | n/r | n/r | n/r | n/r |